No Detail Found!

Determining the potency of cardiac rehabilitation phase- ii in cvd patients with co-morbidities

Author(s)
Sumaira Imran Farooqui Associate Professor/Principal Ziauddin College of Rehabilitation Sciences Ziauddin Universit
Abstract
Globally, cardiovascular disease is a leading cause of mortality and it is estimated that CVD is a cause of approximately 29.6% of all the deaths worldwide. According to a research published in 2015 in American journal of Cardiology it is a time to “rebrand and reinvigorate” the cardiac rehabilitation program as the existing program appears to be neither financially practicable nor maintainable mainly due to affordability barriers. A Quasi-experimental study was conducted on 40 participants whom were diagnosed with cardiovascular disease with comorbidities (diabetes mellitus and dyslipidemia). Participants were asked to enroll in phase-II cardiac rehabilitation program on the recommendation of the cardiologist and were given intervention based on the guideline of American College of Sports medicine. Six weeks of supervised exercise protocol was conducted and its dosage was measured via Frequency, Intensity, Time and Type (FITT) protocol. While for determining the potency of phase-II Cardiac Rehabilitation program assessment of the outcome measures were made after every sessions and the results obtained from the assessment had revealed that for a CVD patients with diabetes 24 hours of exercise which would be performed for not less than four weeks provides a maximal result which carried on for further two weeks whereas for CVD patients with Dyslipidemia 20 hours of exercise had provided a desired result carried on for the remaining weeks. The study concluded that exercises based cardiac rehabilitation had a significant impact in improving the patient condition where a six week of training protocol improves the outcome measures included in the study.
Publication Details
Page(s) 21-31
DOI DOI not available
Published Journal: Pakistan Journal of Rehabilitation, Volume: 7, Issue: 1, Year: 2018

Request the full text from PASTIC

Keywords
ACSM, 6MWT, Potency of Exercise, Dyslipidemia, Diabetes mellitus, WIQ, ABI, Diabetes mellitus, CVD
References
Piepoli MF,Hoes AW,Agewall S,Albus C,Brotons C,Catapano AL,Cooney MT,Corrà U,Cosyns B,Deaton C,Graham I. ESC .2016 .European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J, 37(29) : 2315-81.
Mozaffarian D,Benjamin EJ,Go AS,Arnett DK,Blaha MJ,Cushman M,Das SR,De Ferranti S,Després JP,Fullerton HJ,Howard VJ .2016 .Executive summary: heart disease. update: a report from the American Heart Association. Circulation, 133(4) : 447-54.
Mathers CD,Stevens GA,Boerma T,White RA,Tobias MI .2015 .Causes of international increases in older age life expectancy. The Lancet, 385(9967) : 540-8.
Chatterji S,Byles J,Cutler D,Seeman T,Verdes E .2015 .disability in older adults-present status and future implications. The Lancet, 385(9967) : 563-75.
Galiè N,Humbert M,Vachiery JL,Gibbs S,Lang I,Torbicki A,Simonneau G,Peacock A,Vonk Noordegraaf A,Beghetti M,Ghofrani A. .2015 .ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J, 37(1) : 67-119.
Levine GN,Bates ER,Bittl JA,Brindis RG,Fihn SD,Fleisher LA,Granger CB,Lange RA,Mack MJ,Mauri L,Mehran R. .2016 .AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg, 152(5) : 1243-75.
Murphy TP,Cutlip DE,Regensteiner JG,Mohler III ER,Cohen DJ,Reynolds MR,Massaro JM,Lewis BA,Cerezo J,Oldenburg NC,Thum CC .2015 .Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol, 65(10) : 999-1009.
Fontes-Carvalho R,Sampaio F,Teixeira M,Gama V,Leite-Moreira AF .2015 .The role of a structured exercise training program on cardiac structure and function after acute myocardial infarction: study protocol for a randomized controlled trial. Trials, 16(1) : 90.
Salmoirago_Blotcher E,Wayne PM,Dunsiger S,Krol J,Breault C,Bock BC,Wu WC,Yeh GY .2017 .Tai chi is a promising exercise option for patients with coronary heart disease declining cardiac rehabilitation. J. Am. Heart Assoc, 6(10) : e006603.
Blog RL.,P. RL. .52 .Focus on Fitness: Exercise and Heart Health-Rundown of the Latest Research By Jennifer Van Pelt. MA Today's Dietitian, 20 : .
.2014 .Ethical principles and guidelines for the protection of human subjects of research. The Journal of the American College of Dentists, 81(3) : 4.
0

Citations

0

Downloads

12

Views